首页 | 本学科首页   官方微博 | 高级检索  
检索        


Dietary Milled Flaxseed and Flaxseed Oil Improve N-3 Fatty Acid Status and Do Not Affect Glycemic Control in Individuals with Well-Controlled Type 2 Diabetes
Authors:Carla G Taylor  Amy D Noto  Danielle M Stringer  Sylvia Froese  Linda Malcolmson
Institution:1. Department of Human Nutritional Sciences Winnipeg, Manitoba CANADA ctaylor@cc.umanitoba.ca;3. Department of Human Nutritional Sciences Winnipeg, Manitoba CANADA;4. Department of Human Nutritional Sciences Winnipeg, Manitoba CANADA;5. University of Manitoba, Canadian International Grains Institute Winnipeg, Manitoba CANADA
Abstract:Objective: To determine the effects of dietary consumption of milled flaxseed or flaxseed oil on glycemic control, n-3 fatty acid status, anthropometrics, and adipokines in individuals with type 2 diabetes.

Design: Thirty-four participants were randomized into a parallel, controlled trial.

Subjects: The participants were adults with type 2 diabetes (age 52.4 ± 1.5 years, body mass index 32.4 ± 1.0 kg/m2, n = 17 men and 17 women).

Interventions: Participants consumed a selection of bakery products containing no flax (control group CTL], n = 9), milled flaxseed (FXS, n = 13; 32 g/d), or flaxseed oil (FXO, n = 12; 13 g/d) daily for 12 weeks. The FXS and FXO groups received equivalent amounts of alpha-linolenic acid (ALA; 7.4 g/day).

Measures of Outcome: The primary outcome measures were fasting plasma hemoglobin A1c, glucose, insulin, and phospholipid fatty acid composition. The secondary outcome measures were fasting circulating leptin and adiponectin, as well as body weight, body mass index, and waist circumference. Dietary intake assessment and calculations for homeostasis model assessment for insulin resistance and quantified insulin sensitivity check were also completed.

Results: The FXS and FXO groups had increases in plasma phospholipid n-3 fatty acids (ALA, eicosapentaenoic acid EPA], or decosapentaenoic acid DPA], but not docosahexaenoic acid), and the FXO group had more EPA and DPA in plasma phospholipids compared to the FXS group. All groups had similar caloric intakes; however, the CTL group experienced a 4% weight gain compared to baseline (p < 0.05), while both flax groups had constant body weights during the study period. All other parameters, including glycemic control, were unchanged by dietary treatment.

Conclusions: Milled FXS and FXO intake does not affect glycemic control in adults with well-controlled type 2 diabetes. Possible prevention of weight gain by flax consumption warrants further investigation.
Keywords:human  type 2 diabetes mellitus  milled flaxseed  flaxseed oil  α-linolenic acid  glucose  insulin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号